Evidence map›Paper›PMID 41994507›Full record

ArticleFrontiers in public health2026

Clinical characteristics and etiological analysis of deep fungal infections in a general hospital in Southwest China (2020-2024).

Shuwei Zhao, Rui Su, Zhenghui Yang, Yuye Li, Yi-Qun Kuang, Hongbin Li

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuwei Zhao *Department of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Rui Su *Department of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhenghui YangDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yuye LiDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yi-Qun KuangResearch Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China.
Hongbin LiDepartment of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deep fungal infections (DFIs) represent a significant and growing threat to hospitalized patients, contributing to substantial morbidity and mortality worldwide. The healthcare landscape has undergone notable changes in recent years, particularly with the impact of the COVID-19 pandemic, which has altered host immunity and care pathways, potentially influencing the epidemiology of DFIs. Objective: This study aimed to delineate the clinical characteristics, mycological profiles, risk factors of deep fungal infections, and to evaluate factors associated with mortality among inpatients in a general hospital in southwestern China from 2020 to 2024. Methods: This was a retrospective analysis of 886,056 patients in the hospital from 2020 to 2024, including the epidemiological characteristics, treatment, and prognosis of deep fungal infections. Results: A total of 462 cases (0.052%) with deep fungal infections were identified, accounting for 0.052% of the total number of hospitalizations. The incidence of deep fungal infections in the hospital showed an increasing trend from 2020 to 2024. Compared with previous studies, Conclusions: Compared with earlier research (2015-2019), the number of deep fungal infection cases from 2020 to 2024 has shown a significant and sustained increase. Moreover, the threat posed by

Indexed as

Hospitals, GeneralMycosesAdultAgedChinaCOVID-19FemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsAspergillusbiological agentsdeep fungal infectionepidemiologyprognosisrisk factors

Identifiers

PMID41994507
PMCPMC13080720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.